The Loophole: "Research Chemicals" Retailers sell peptides with disclaimers: "For research purposes only" "Not for human consumption" "Laboratory use only" Meanwhile: Influencers inject them on camera Websites provide dosing guides Retailers offer "coaching" Affiliate links everywhere It's the exact same product
Rebound Weight Gain In some cases, patients may experience rebound weight gain after discontinuing Semaglutide treatment
Renal injury in the extremely obese patients with normal renal function
Reducing Other Medications A significant benefit of GLP-1 treatment is often simplifying medication regimens: Insulin reduction or discontinuation: Many patients on insulin reduce doses substantially, sometimes discontinuing insulin entirely
[112] describe how lithium may be related to aging processes that involve protein secretion, ultimately resulting in neurodegenerative diseases such as Parkinsons Disease (PD)
Because of the unprecedented demand for these medications, many are in limited supply including Ozempic and Victoza (liraglutide), which Novo Nordisk confirmed will be in short supply until at least fall of 2024
